It will be important to examine if N-terminally truncated BRAF, as detected in several human cancers, is linked with phosphorylated MEK nuclear accumulation and whether this is associated with any of the key biochemical and cellular characteristics previously linked with aberrant MEK localisation. This evidence concerns the gene BRAF and cancer.